Lipoprotein(a)-cholesterol: A significant component of serum cholesterol

被引:58
作者
Kinpara, Kiyoko [2 ]
Okada, Hiroshi [3 ]
Yoneyama, Akiko [2 ]
Okubo, Minoru [1 ,4 ]
Murase, Toshio [1 ,4 ]
机构
[1] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan
[2] Toranomon Gen Hosp, Dept Clin Lab, Tokyo, Japan
[3] Sanwa Kagaku Kenkyusho Co Ltd, Dev Grp, Diagnost Business Dept, Nagoya, Aichi, Japan
[4] Toranomon Gen Hosp, Dept Endocrinol & Metab, Tokyo, Japan
关键词
Lipoprotein(a); Lipoprotein(a)-cholesterol; The Friedewald formula; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; RISK-FACTOR; PLASMA; HETEROGENEITY; IMPACT;
D O I
10.1016/j.cca.2011.05.036
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Lipoprotein(a) [Lp(a)] is known to be a cholesterol-rich lipoprotein, however, the contribution of Lp(a)-cholesterol [Lp(a)-C] to the serum cholesterol and LDL-C levels has not yet been fully evaluated. Methods: We determined the serum Lp(a)-C in 55 subjects with serum Lp(a) concentrations ranging from 9 to 129 mg/dl. To measure the serum Lp(a)-C concentrations, we developed an immunoaffinity gel assay; serum was incubated with Sepharose 4B gel coupled with immunoglobulin G (IgG) prepared from a polyclonal anti-Lp(a) goat antiserum. After separating Lp(a) from other lipoproteins, we determined the serum Lp(a)-C concentrations. Validation of the assay showed satisfactory results in terms of the specificity and reproducibility. Results: The mean cholesterol content of Lp(a), determined as Lp(a)-C/Lp(a), was 29.5 +/- 10.4%. The serum Lp(a)-C values were found to be highly correlated with the serum Lp(a) mass (r=0.923, p<0.001). At serum Lp(a) levels of over 50 mg/dl, the contribution of Lp(a)-C to the serum total cholesterol was 10.2%. Further, the Friedewald formula overestimated the serum LDL-C by 20.4%. Conclusions: Lp(a) contains approximately 30% cholesterol in each molecule. In subjects with markedly elevated serum Lp(a) concentrations, the Lp(a)-C values should be taken into account when evaluating the serum LDL-C. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1783 / 1787
页数:5
相关论文
共 20 条
  • [11] Kostner GM, 1999, J LIPID RES, V40, P2255
  • [12] LI KM, 1994, CLIN CHEM, V40, P571
  • [13] Marcovina SM, 2000, CLIN CHEM, V46, P1956
  • [14] Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus
    Murase, Toshio
    Okubo, Minoru
    Amemiya-Kudo, Michiyo
    Ebara, Tetsu
    Mori, Yasumichi
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (06): : 791 - 795
  • [15] Impact of markedly elevated serum lipoprotein(a) levels (≥100 mg/dL) on the risk of coronary heart disease
    Murase, Toshio
    Okubo, Minoru
    Amemiya-Kudo, Michiyo
    Hiraga, Takaki
    Oka, Junko
    Shimada, Masako
    Igarashi, Tomio
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (09): : 1187 - 1191
  • [16] Lipoprotein(a) as a cardiovascular risk factor: current status
    Nordestgaard, Borge G.
    Chapman, M. John
    Ray, Kausik
    Boren, Jan
    Andreotti, Felicita
    Watts, Gerald F.
    Ginsberg, Henry
    Amarenco, Pierre
    Catapano, Alberico
    Descamps, Olivier S.
    Fisher, Edward
    Kovanen, Petri T.
    Kuivenhoven, Jan Albert
    Lesnik, Philippe
    Masana, Luis
    Reiner, Zeljko
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Tybjaerg-Hansen, Anne
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (23) : 2844 - U14
  • [17] LIPOPROTEIN (A) - HETEROGENEITY AND BIOLOGICAL RELEVANCE
    SCANU, AM
    FLESS, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) : 1709 - 1715
  • [18] SEMAN LJ, 1994, CLIN CHEM, V40, P400
  • [19] Seman LJ, 1999, CLIN CHEM, V45, P1039
  • [20] Utermann G., 2001, METABOLIC MOL BASES, V8th, P2753